Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Integration of viral hepatitis services into opioid treatment programs.

Kresina TF, Bruce RD, Lubran R, Clark HW.

J Opioid Manag. 2008 Nov-Dec;4(6):369-81.

PMID:
19192765
2.

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

Spire B, Lucas GM, Carrieri MP.

Int J Drug Policy. 2007 Aug;18(4):262-70. Epub 2007 Jan 26. Review.

PMID:
17689374
3.

Access to treatment-related and support services in methadone treatment programs.

Berkman ND, Wechsberg WM.

J Subst Abuse Treat. 2007 Jan;32(1):97-104. Epub 2006 Oct 27.

PMID:
17175403
4.

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. Review.

PMID:
17109306
5.
6.

Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.

Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.

J Subst Abuse Treat. 2007 Jul;33(1):85-90. Epub 2007 Jan 9.

PMID:
17588493
7.

Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).

[No authors listed]

J Addict Dis. 2005;24(3):153-61. No abstract available.

PMID:
16186090
8.

Methadone therapy for opioid dependence.

Krambeer LL, von McKnelly W Jr, Gabrielli WF Jr, Penick EC.

Am Fam Physician. 2001 Jun 15;63(12):2404-10. Review.

9.

Methadone maintenance treatment. When and how to refer patients.

DeMaria PA Jr, Weinstein SP.

Postgrad Med. 1995 Mar;97(3):83-6, 91-2. Review.

PMID:
7877931
10.

Integration of pharmacotherapy for opioid addiction into HIV primary care for HIV/hepatitis C virus-co-infected patients.

Kresina TF, Eldred L, Bruce RD, Francis H.

AIDS. 2005 Oct;19 Suppl 3:S221-6. Review.

PMID:
16251822
11.

The medical management of opioid dependence in HIV primary care settings.

Lum PJ, Tulsky JP.

Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. Review.

PMID:
17089480
12.

Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.

Trafton JA, Tracy SW, Oliva EM, Humphreys K.

J Stud Alcohol Drugs. 2007 Mar;68(2):165-72.

PMID:
17286334
13.

Gaps in the drug-free and methadone treatment program response to Hepatitis C.

Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H.

J Subst Abuse Treat. 2003 Jun;24(4):291-7.

PMID:
12867202
14.

[Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].

Popov P, Becka J, Wilczek H.

Vnitr Lek. 2003 Nov;49(11):851-8. Czech.

PMID:
14689681
15.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
16.

A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.

King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK.

J Subst Abuse Treat. 2006 Dec;31(4):385-93. Epub 2006 Aug 14.

PMID:
17084792
17.

The prevalence of mental and physical health disorders among older methadone patients.

Rosen D, Smith ML, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2008 Jun;16(6):488-97. doi: 10.1097/JGP.0b013e31816ff35a.

PMID:
18515693
18.

New federal regulations for improving quality in opioid treatment programs.

Pelletier LR, Hoffman JA.

J Healthc Qual. 2001 Nov-Dec;23(6):29-34.

PMID:
23413476
19.

Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Kahan M, Sutton N.

Can Fam Physician. 1996 Sep;42:1769-78. Review.

20.

Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.

Greenberg B, Hall DH, Sorensen JL.

J Psychoactive Drugs. 2007 Sep;39(3):203-10. Review.

PMID:
18159773

Supplemental Content

Support Center